Crystagen vs Vitamin D3 Injection
A side-by-side research comparison of Crystagen and Vitamin D3 Injection across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Crystagen | Vitamin D3 Injection |
|---|---|---|
| Full name | Crystagen (Immune Peptide Bioregulator) | Cholecalciferol (Vitamin D3) Injectable |
| Category | Immune Support | Immune Support |
| Status | Research compound (peptide bioregulator) | Compounded supplement |
| Mechanism | As a signal peptide, it is proposed to enter cells and regulate gene expression in immune tissue, supporting normal thymic and lymphoid function, immune cell maturation, and balanced immune responses. | Converts to 25-hydroxyvitamin D then to active 1,25-dihydroxyvitamin D. Modulates over 200 genes including those for immune function, calcium absorption, bone remodeling, and hormone production. |
| Molecular weight | ~ (short peptide) | 384.64 Da |
| Half-life | Short (peptide) | ~15 days (storage form) |
| Bioavailability | Oral (encapsulated) or subcutaneous | ~100% IM |
| Typical dose | ~1-2 capsules/day or short injectable courses | 50,000-100,000 IU |
| Frequency | Once daily | Weekly to monthly |
| Route | Oral capsule or subcutaneous | Intramuscular injection |
Crystagen reported benefits
- Immune regulation support
- Thymic/lymphoid tissue support (proposed)
- Immune resilience
- Short course-based protocol
- Part of bioregulator longevity systems
Vitamin D3 Injection reported benefits
- Rapid deficiency correction
- Immune system optimization
- Bone health
- Hormone support
- Mood improvement
- Reduced inflammation
Related comparisons
Research and educational reference only. Not medical advice.